JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Right arrow Help viewing high resolution images
Right arrow Return to article
Click on image to view larger version.



FIGURE 2. Striatal DAT availability (V3'') vs. age (in years) as measured by 123I-ß-CIT SPECT in 94 healthy European Americans grouped according to SLC6A3 VNTR genotype. SLC6A3*9R carriers (n = 41) had significantly higher striatal DAT availability (V3'') than did SLC6A3*10R homozygotes (n = 53), controlling for age (F1,93 = 6.25, P = 0.014, ANCOVA). Both genotypic subgroups showed similar aging effects: For *9R carriers, V3'' declined by 44% over age range 18–88 y, or approximately 6.3% per decade. For *10R homozygotes, V3'' declined by 43% over age range 18–88 y, or approximately 6.2% per decade.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE